UCeed Health Fund
Focused on advancing health care innovation across the field, including areas like therapeutics, diagnostics, medical devices and software.
Activated by Innovate Calgary, the university’s knowledge transfer and business incubator, UCeed serves to support the robust pipeline of UCalgary-based health enterprises.
UCeed Health Fund is supported by the generosity of the River Fund at the Calgary Foundation and their mission to build a healthy and vibrant community where everyone belongs.
Health is a state of complete mental, social and physical well-being, not merely the absence of disease or infirmity.
The World Health Organization
Uceed accepts applications on an ongoing basis.
Investment and fund eligibility
Investment
$50,000 up to $300,000
Criteria
- Applicant must have an established relationship with the University of Calgary as a current, past or visiting faculty member, a student, or has licensed or assigned intellectual property developed at the University of Calgary.
- For-profit enterprise
- Technology Readiness Level (TRL): Stage 1-9
- Must be incorporated prior to receipt of funds
- Minimum one (1) full-time employee within six (6) months of UCeed investment
Our Investments
Learn more about our investments and how hey are making an impact.
Investment Advisory Group - Health Fund
Mike Begin
Meg Bregazzi
Chen Fong
Derrick Hunter
Zain Kassam
James Lochrie
Alice Reimer
Clinical Advisory Board
The marketplace success of novel therapeutics, diagnostics, medical devices, and other healthcare products often depends on nuanced factors that require frontline clinician feedback to assess. The Clinical Advisory Board (CAB) is a group of physician volunteers who leverage their networks to connect UCeed Health staff to frontline clinicians who provide feedback on the clinical utility and feasibility of healthcare products and services in development by prospective investee companies. We are deeply grateful for their valuable assistance.
Health Fund Portfolios
All Skin
All Skin is making it easier for people with skin conditions to measure sensitivities and find the right products adapted to their needs, through its bespoke at-home patch test and mobile app.
Circle Neurovascular Imaging
Circle Neurovascular Imaging is on a mission to improve the outcomes of stroke patients through its clinically validated StrokeSENSTM technology. Using AI-assisted advanced technology, it can identify the right treatments for patients more quickly than traditional methods.
Deep Surface AI
Deep Surface AI is developing cosmetic surgery software that uses artificial intelligence and high-resolution models of human facial shape variation to provide fast and accurate cosmetic surgery planning.
Difinity Solutions
Difinity Solutions — through it flagship device, NeedSwitch — is advancing disruptive technologies to deliver lifesaving medications in emergency situations.
Fluid Biomed
Fluid Biomed is developing a bioabsorbable flow diversion stent to treat brain aneurysms that offer improved safety and post-surgical brain imaging over conventional metallic stents.
freddie
PurposeMed has developed a digital platform, Freddie, to provide quick, discrete and expert telemedicine services to prescribe and deliver HIV pre-exposure prophylaxis (PrEP) drugs to vulnerable populations, reducing the incidence of HIV infection and healthcare costs.
HelpWear
HelpWear is developing a non-invasive, wearable, heart-monitoring system to record and diagnose heart rhythm disorders that offers substantial ease-of-use and longer patient recording time over conventional medical devices.
ILLUCIDx
ILLUCIDx founders are developing a point-of-care diagnostic device that is simple, fast to use, accessible by more people in more places and able to produce results in minutes.
InventoRR MD
InventoRR MD is commercializing groundbreaking trauma and surgery devices, like the AbClo, to create better outcomes for patients, reduce surgery times and lower healthcare costs.
MACH32
MACH32 brings together expertise in engineering and health sciences to create innovative medical devices that protect lives.
Medhesion
Medhesion is developing a solution for post-surgery abdominal adhesions, a potentially life-threatening complication that affects hundreds of thousands of patients each year.
Nimble Science
Nimble Science is developing an ingestible, medical-device capsule that samples small intestine contents for microbiome diagnostic applications, obviating the need for invasive endoscopy procedures.
Noa Therapeutics
Noa Therapeutics is developing multimodal therapeutics to address the complexity of immune diseases, innovation that will help break the cycle of trial-and-error treatment failures
Oncoustics
Oncoustics is accelerating the detection and surveillance of disease through its AI-powered technology that measures the sound in ultrasound.
PulseMedica
PulseMedica is developing a medical device to treat retinal eye diseases that affect more than 400 million people worldwide. Its state-of-the-art technology will improve patient outcomes and quality of life.
Qualisure Diagnostics
Qualisure is developing a precision diagnostic test to guide the treatment of thyroid cancer, improving patient outcomes by reducing unnecessary surgical procedures and chemotherapy treatments and saving healthcare costs.
Reach Orthopaedics
Reach Orthopaedics is developing a shoulder implant to treat patients suffering from massive, irreparable rotator cuff tears. Its design can increase mobility and function while eliminating chronic pain.
Syantra DX
Syantra Diagnostics is developing a blood-based diagnostic test to detect breast cancer.
Tactile Orthopaedics
Tactile Orthopaedics manufactures anatomically accurate human joint models that incorporate artificial bone, cartilage and tendon components that have material properties that mimic that of living human tissue for arthroscopic surgical training, providing a cost-effective alternative to human cadaveric samples.
ViTAA Medical Solutions
ViTAA Medical Solutions is using AI and diagnostic imaging to help doctors assess aortic aneurysms more accurately and ensure that patients receive the lifesaving care they need.
Zymedyne
Zymedyne is developing therapeutics for the treatment of chronic pain that targets a recently discovered biological process that is abnormally activated in chronic pain conditions, offering an alternative to opioids.